Chemotherapy News and Research

Latest Chemotherapy News and Research

High PD-L1 expression linked to reduced survival in NSCLC

Overexpression of programmed death-ligand 1 is independently associated with the presence of epidermal growth factor receptor gene mutations and poor prognosis in patients with non-small-cell lung cancer, Japanese researchers report.

28 Aug 2014

Scientists explore ways to personalise radiotherapy dose given to lung cancer patients

Manchester scientists are working out how to safely increase the radiotherapy dose given to lung cancer patients - potentially offering improved local control and survival.

From The University of Manchester 28 Aug 2014

Contaminated blood cultures can serve as diagnostic predictor for more targeted antibiotics

Some 30 percent of all positive hospital blood culture samples are discarded every day because they're "contaminated" - they reflect the presence of skin germs instead of specific disease-causing bacteria.

28 Aug 2014

Versatile nanoparticles offer wide variety of diagnostic and therapeutic applications

Kit Lam and colleagues from UC Davis and other institutions have created dynamic nanoparticles (NPs) that could provide an arsenal of applications to diagnose and treat cancer.

27 Aug 2014

Scientists find that DNA repair drug could help treat leukaemia, other cancers

A team of scientists led by Research Associate Professor Motomi Osato and Professor Yoshiaki Ito from the Cancer Science Institute of Singapore at the National University of Singapore found that a drug originally designed for killing a limited type of cancer cells with DNA repair defects could potentially be used to treat leukaemia and other cancers.

26 Aug 2014

Repurposing anti-depressant medication to target new pathway may help combat medulloblastoma

An international research team reports in Nature Medicine a novel molecular pathway that causes an aggressive form of medulloblastoma, and suggests repurposing an anti-depressant medication to target the new pathway may help combat one of the most common brain cancers in children.

26 Aug 2014

Experts available to share tips on prevention of ovarian cancer

Ovarian cancer is the fourth leading cause of death in American women, with about 22,000 diagnosed and 14,000 dying from the disease each year. September is Ovarian Cancer Awareness month and Mount Sinai experts are sharing tips on prevention.

26 Aug 2014

Drug to kill limited type of cancer cells with DNA repair defects could treat leukaemia

A team of scientists led by Research Associate Professor Motomi Osato and Professor Yoshiaki Ito from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) found that a drug originally designed for killing a limited type of cancer cells with DNA repair defects could potentially be used to treat leukaemia and other cancers.

26 Aug 2014

Researchers examine impact of BIM deletion on survival outcomes of advanced NSCLC patients

Bcl-2-like protein 11 (BIM) deletion in advanced non-small cell lung cancer (NSCLC) is associated with shorter progression free survival (PFS) in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) or chemotherapy treated Asian patients.

25 Aug 2014

ESMO announces names of outstanding individuals receiving annual awards

The European Society for Medical Oncology, the leading pan-European organisation representing medical oncologists, announced the names of outstanding individuals receiving the Society's esteemed annual awards, to be presented during the ESMO 2014 Congress, on 26 September, in Madrid.

22 Aug 2014

Sen. Pryor debuts campaign ad embracing health law provisions

The Arkansas Democrat, who is in a tough reelection fight, talked about his own struggle with cancer and how the health law provisions that prohibit insurance companies from denying coverage to people with medical problems could have helped him.

22 Aug 2014

Pre-op PET/CT predicts stage I NSCLC adjuvant chemotherapy benefit

Preoperative imaging could help guide the use of postoperative adjuvant chemotherapy in patients with early non-small-cell lung cancer, Japanese researchers believe.

21 Aug 2014

Erlotinib feasible in KRAS wild-type lung adenocarcinoma

Erlotinib is a valid treatment option for patients with KRAS wild-type lung adenocarcinoma refractory to chemotherapy, study data show.

21 Aug 2014

First Edition: August 21, 2014

Today's early morning highlights from the major news organizations, including reports about a new "Obamacare" ad in the Arkansas Senate race and a California poll measuring how the state's voters feel about a ballot initiative that would expand the state's ability to regulate health insurance rates.

21 Aug 2014

Scientists discover predictive marker to classify breast cancer patients for effective treatment

Scientists have made it easier to predict both breast cancer relapses and responses to chemotherapy, through the identification of a unique gene. The newly found marker could help doctors classify each breast cancer patient and customise a treatment regimen that is more effective.

21 Aug 2014

Plymouth University selects Brain Tumour Research as official charity partner

Brain Tumour Research has been chosen by Plymouth University to be an official charity partner. Brain Tumour Research was launched in April 2009 to raise awareness of, and funding for, scientific research into brain tumours and improve outcomes for brain tumour patients.

21 Aug 2014

Blocking nerve signals could be effective treatment for stomach cancer

Research from Columbia University Medical Center shows that nerves may play a critical role in stomach cancer growth and that blocking nerve signals using surgery or Botox® (onabotulinumtoxinA) could be an effective treatment for the disease.

21 Aug 2014

EGFR biomarkers predict NSCLC response to vandetanib

Biomarker analyses of tumour samples from the ZODIAC study indicate that epidermal growth factor receptor gene copy number and mutation status may help identify the non-small-cell lung cancer patients most likely to benefit from treatment with vandetanib plus docetaxel.

20 Aug 2014

CD157 important in malignant pleural mesothelioma

CD157 plays a pivotal role in the progression of malignant pleural mesothelioma and may be useful in the stratification of patients into different prognostic groups, Italian research suggests.

20 Aug 2014

Scientists identify biomarker strongly associated with aggressive breast cancer

Two Northwestern University scientists have identified a biomarker strongly associated with basal-like breast cancer, a highly aggressive carcinoma that is resistant to many types of chemotherapy. The biomarker, a protein called STAT3, provides a smart target for new therapeutics designed to treat this often deadly cancer.

20 Aug 2014

Chemotherapy News and Research

Latest Chemotherapy News and Research

High PD-L1 expression linked to reduced survival in NSCLC

Scientists explore ways to personalise radiotherapy dose given to lung cancer patients

Contaminated blood cultures can serve as diagnostic predictor for more targeted antibiotics

Versatile nanoparticles offer wide variety of diagnostic and therapeutic applications

Scientists find that DNA repair drug could help treat leukaemia, other cancers

Repurposing anti-depressant medication to target new pathway may help combat medulloblastoma

Experts available to share tips on prevention of ovarian cancer

Drug to kill limited type of cancer cells with DNA repair defects could treat leukaemia

Researchers examine impact of BIM deletion on survival outcomes of advanced NSCLC patients

ESMO announces names of outstanding individuals receiving annual awards

Sen. Pryor debuts campaign ad embracing health law provisions

Pre-op PET/CT predicts stage I NSCLC adjuvant chemotherapy benefit

Erlotinib feasible in KRAS wild-type lung adenocarcinoma

First Edition: August 21, 2014

Scientists discover predictive marker to classify breast cancer patients for effective treatment

Plymouth University selects Brain Tumour Research as official charity partner

Blocking nerve signals could be effective treatment for stomach cancer

EGFR biomarkers predict NSCLC response to vandetanib

CD157 important in malignant pleural mesothelioma

Scientists identify biomarker strongly associated with aggressive breast cancer

Cancer Research - Second Edition eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in